Intelligence Platform

Patents

Browse 429 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9476037

Factor VII polypeptides that are modified and uses thereof

Catalyst Biosciences, Inc. · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9469664

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

Sarepta Therapeutics, Inc. · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9457075

Modified foot and mouth disease virus (FMDV) VP1 capsid protein

The Pirbright Institute · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9453078

Modified antibody compositions, methods of making and using thereof

CytomX Therapeutics, Inc. · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9453239

Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag a

The Government of the United States of America, as represented by the Secretary Department of Health and Human Services, National Institutes of Health · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9447406

Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9446067

Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modi

BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9421204

Oligomer modified diaromatic substituted compounds

Nektar Therapeutics · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9416360

Base modified oligonucleotides

MIRAGEN THERAPEUTICS, INC. · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9394540

Modified iRNA agents

Alnylam Pharmaceuticals, Inc. · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9388222

Modified Pseudomonas exotoxin A

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9388104

Chemically modified small molecules

Nektar Therapeutics · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9371352

Modified glycolipids and methods of making and using the same

VACCINEX, INC. · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9370525

Modified release preparations containing oxcarbazepine and derivatives thereof

Supernus Pharmaceuticals, Inc. · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9351975

Modified release preparations containing oxcarbazepine and derivatives thereof

Supernus Pharmaceuticals, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9328339

Modified factor IX polypeptides and uses thereof

Catalyst Biosciences, Inc. · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9328140

Modified mini-hepcidin peptides and methods of using thereof

The Regents of the University of California · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9320814

Polyplexes of hydrophobically-modified siRNA for delivery of siRNA

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9321799

Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

Ionis Pharmaceuticals, Inc. · Granted Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9301509

Genetically modified mice and engraftment

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9303068

D-amino acid derivative-modified peptidoglycan and methods of use thereof

The Regents of the University of California · Granted Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9290760

Modified iRNA agents

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9278987

Functionally-modified oligonucleotides and subunits thereof

Sarepta Therapeutics, Inc. · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9265818

Genetically modified Babesia parasites expressing protective tick antigens and uses thereo

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted